New Hampshire Senate Bill SB504

New Hampshire 2026 Regular Session

• Introduced: 11/21/25
• Refer: 11/21/25
• Report Pass: 3/18/26
• Engrossed: 3/27/26
• Refer: 3/27/26
• Report Pass: 5/1/26

Caption

Relative to the practice of pharmacy and the dispensing of certain medications by pharmacists, authorizing the establishment of experimental treatment centers, and permitting treatment of certain severe illness under the right to try act.

Impact

The bill makes critical amendments to the regulation of pharmacies, including changes to display requirements for licenses and permits. It allows advanced pharmacy technicians to engage in remote processing of medications, thus adapting to modern pharmacy practices that leverage technology to improve efficiency and accessibility. Additionally, the bill eliminates the requirement for a pharmacist’s name on medication labels, streamlining the labeling process while maintaining necessary drug information.

Summary

Senate Bill 504 addresses the practice of pharmacy in New Hampshire, focusing on the dispensing of noncontrolled oral anti-cancer medications. The bill authorizes licensed health care professionals to dispense a 30-day supply of these medications under specific conditions, including the presence of a licensed pharmacist available for consultation. This provision aims to enhance patient access to vital cancer treatments while ensuring safety through professional supervision.

Contention

However, the bill has sparked some controversy regarding the scope of pharmacy practice and the role of pharmacists in patient care. Critics may argue that allowing non-pharmacists to dispense medication could lead to safety concerns, particularly regarding drug interactions and patient counseling. Moreover, removing certain examination requirements for licensure as an advanced pharmacy technician has raised questions about the competency and preparedness of pharmacy staff in a rapidly evolving healthcare environment. Proponents, on the other hand, assert that these changes will facilitate patient access to treatments while maintaining quality care standards.